← FDA DRUG APPROVALS

FDA ANDA · ANDA205442

LINEZOLID

Sponsor: HOSPIRA

APPLICATION
ANDA205442
TYPE
ANDA
ORIGINAL APPROVAL
2015-07-07
LATEST ACTION
2019-06-21
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

LINEZOLIDDiscontinued
LINEZOLID 600MG/300ML (2MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2019-06-21Labeling · Supplement 1 · standardAP
2019-06-21Labeling · Supplement 2 · standardAP
2015-07-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →